适应医疗
AHCO
6.02
-0.37
-5.79%
适应医疗
US · AHCO
#3414 按市值排名
6.02
-0.37
-5.79%
实时 - 追踪5344个代码 - 心跳于266秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
增持
- 最近一期（2026/Q3）披露持股的机构数量增加了3家。
- 机构持股总比例上升了0.3个百分点。
机构持股
- 机构持股比例
- 107.76% +0.32pp
- 机构数量
- 290 +3
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向分歧机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向出现分歧。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund71.14%
VC/PE Fund18.66%
Hedge Fund12.88%
Individual/Insider8.42%
Government Pension Fund1.91%
Public Company1.70%
Private Company0.75%
Insurance Company0.29%
Sovereign Wealth Fund0.19%
主要股东 截至 2026-06-30
OEP Capital Advisors L.P.
12.23% · 16.31M 股
BlackRock
12.04% · 16.06M 股
Deerfield Management Company, L.P.
8.60% · 11.48M 股
SkyKnight Capital, L.P.
6.43% · 8.58M 股
Wayne Quasha
6.22% · 8.30M 股
FMR
5.91% · 7.88M 股
Dimensional Fund Advisors
5.75% · 7.67M 股
Reinhart Partners, LLC
5.56% · 7.42M 股
Vanguard Portfolio Management, LLC
4.82% · 6.43M 股
Vanguard Capital Management, LLC
4.16% · 5.55M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 42次买入 · 6次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| OEP Capital Advisors L.P. | -- | 12.23% |
| Theodore Lundberg | Independent Director | 0.64% |
| Jason Clemens | Chief Financial Officer | 0.28% |
| Richard Barasch | Chairman of the Board & Interim CEO | 0.23% |
| Suzanne Foster | Interim CEO | 0.16% |
| Albert Prast | Chief Technology Officer | 0.16% |
| Dale Wolf | Independent Director | 0.12% |
| Russell Schuster | Chief Commercial Officer | 0.09% |
| Christine Archbold | Chief Accounting Officer | 0.08% |
| Susan Weaver | Independent Director | 0.07% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-08 | Harriss Currie | Chief Financial Officer | Other Acquisition | +141,372 | -- |
| 2026-09-08 | Harriss Currie | Chief Financial Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-08-05 | Dale Wolf | Independent Director | Open Market Acquisition | +20,000 | $6.30 |
| 2026-08-05 | Kenneth Samet | Independent Director | Open Market Acquisition | +23,500 | $6.38 |
| 2026-06-30 | Russell Schuster | Chief Commercial Officer | Automatic Disposition | -11,275 | $10.44 |
| 2026-06-23 | Dale Wolf | Independent Director | Other Acquisition | +18,999 | -- |
| 2026-06-23 | Theodore Lundberg | Independent Director | Other Acquisition | +18,999 | -- |
| 2026-06-23 | Kenneth Samet | Independent Director | Other Acquisition | +25,069 | $9.89 |
| 2026-06-23 | Gregory Belinfanti | Independent Director | Other Acquisition | +18,999 | -- |
| 2026-06-23 | Bradley Coppens | Independent Director | Other Acquisition | +18,999 | -- |
| 2026-06-23 | David Williams | Independent Director | Other Acquisition | +18,999 | -- |
| 2026-06-23 | Susan Weaver | Independent Director | Other Acquisition | +18,999 | -- |
| 2026-06-23 | Terence Connors | Independent Director | Other Acquisition | +18,999 | -- |
| 2026-05-31 | Russell Schuster | Chief Commercial Officer | Automatic Disposition | -11,275 | $10.06 |
| 2026-05-26 | Daniel McFadden | Chief Business Systems Officer | Other Acquisition | +20,134 | -- |
| 2026-03-19 | OEP Capital Advisors L.P. | -- | Open Market Acquisition | +447,827 | $9.91–9.94 |
| 2026-03-12 | Albert Prast | Chief Technology Officer | Sale to Issuer | -58,203 | $10.33 |
| 2026-03-12 | Albert Prast | Chief Technology Officer | Derivative Exercise and Retained | +89,451 | $4.38 |
| 2026-03-04 | Susan Weaver | Independent Director | Other Acquisition | +73,472 | -- |
| 2026-03-04 | Susan Weaver | Independent Director | Other Disposition | -73,472 | -- |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
适应医疗 讨论区 0 条评论